Skip to main content
Premium Trial:

Request an Annual Quote

LSBC, Icon Genetics in Biomanufacturing Deal with Ukrainian Government

NEW YORK, Dec. 3-Large Scale Biology Corporation and Germany's Icon Genetics have signed an agreement with the Ukrainian government to develop plant-produced pharmaceuticals, LSBC said in a statement today.

 

The two companies plan to work with Ukrainian scientists to develop transgenic plants that can produce pharmaceutical quality proteins.

 

The Vice Prime Minister of Ukraine, Volodymyr Seminozhenko, signed a letter of intent with the two companies on November 5th, according to LSBC.

 

LSBC is developing a biomanufacturing process, Geneware, and claims to have built the world's first commercial scale plant pharmaceutical production center.

 

Icon Genetics, based in Munich, is working on agricultural biotechnology techniques.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.